Country Brand Manager, Vaccines

Role OverviewThe Country Brand Manager (CBM) for Prevenar 20 Paediatrics, Singapore is responsible for driving brand growth through strong execution of the commercial plan, grounded in clear prioritization of paediatric segments and market opportunities. The CBM develops the mindset and capabilities of a brand general manager — demonstrating ownership over the brand growth agenda, clarity on where to play and how to win, and the ability to identify what is not working and adapt with agility.Key Capabilities1. Paediatric Vaccine Market & Business AcumenA strong CBM must demonstrate solid understanding of:Paediatric pneumococcal disease burden and target segments — infants, children under 5, pre-term, and immunocompromised populationsSingapore's private and public market dynamics — including private paediatricians, GP clinics, polyclinics, and the Childhood Immunisation Programme (CIP) under MOHCompetitive landscape — PCV10, PCV13, PCV15, and PCV20 dynamics, including positioning relative to national schedule recommendations and private market brand choiceAccess levers — working understanding of MediShield Life, Medisave, and CHAS subsidies as drivers of uptakeThe CBM can clearly articulate where to play and how to win beyond promotion alone.2. Brand Ownership & Growth Plan AccountabilityThe CBM takes genuine ownership of the brand plan, not just its execution:Develops and champions prioritized growth opportunities anchored in clear segmentation choicesSupports alignment of internal stakeholders — sales, medical, and access — around brand directionContributes meaningfully to OP/LE planning and tracks brand performance against planBegins to connect brand outcomes to Singapore and MISP Cluster priorities3. Patient & Parent Funnel UnderstandingPrevenar Paeds plans are fundamentally funnel-driven, with parents and caregivers as the primary decision-makers:Maps the full funnel: Awareness → Concern → Recommendation → Access → Brand Choice → VaccinationTracks funnel metrics and identifies where conversion is breaking downDesigns demand-creation activities beyond detailing — parent education, caregiver materials, clinic workflow support, and affordability messaging4. Diagnosis & Execution AgilityA strong CBM does not wait to be told what to fix. They:Read performance data (IQVIA, sales, funnel metrics) and proactively flag where plans are underperformingPropose and execute course corrections with a bias for actionAdapt quickly when market conditions shift, without losing sight of the overall brand strategyLearn from each execution cycle and apply insights forward5. Field Force Collaboration & ExecutionWorks closely with the sales team to translate brand strategy into field execution:Develops clear messaging frameworks, call plan priorities, and targeting guidance (paediatricians, GPs, MCH clinics)Builds rep-ready materials that are simple, relevant, and easy to deliverMaintains a collaborative and credible relationship with the field team6. Cross-Functional CollaborationEngages Medical, Access, and other functions as a collaborative partner:Works with Medical Affairs to support KOL engagement and scientific programmesPartners with Access on CIP and private market affordability leversCommunicates clearly and professionally across teams and levels7. Portfolio AwarenessUnderstands how Prevenar 20 Paeds fits within the broader paediatric and maternal immunisation portfolio, and coordinates messaging and activities accordingly.8. Marketing Fundamentals & EMPOWER FrameworkThe CBM applies core marketing disciplines rigorously and consistently:Leverages the EMPOWER framework as the foundation for brand planning, ensuring strategic choices are grounded in a structured, insight-led approachCompetent in core marketing fundamentals — segmentation, targeting, positioning, messaging, and campaign executionTranslates framework outputs into clear, actionable brand plans that the broader team can align behind and execute against9. AI Fluency & Learning AgilityThe CBM embraces new ways of working and is willing to continuously evolve:Demonstrates AI fluency — actively explores and incorporates AI tools to improve the quality, speed, and impact of marketing workApproaches AI as a force multiplier for brand planning, content development, data analysis, and stakeholder communicationShows a growth mindset and agility in learning — open to new methodologies, tools, and ways of working as the commercial environment evolvesModels curiosity and adaptability, inspiring the same in peers and collaboratorsQualificationsDegree in Life Sciences, Business, or related field2–4 years of pharmaceutical marketing or commercial experience; vaccines or paediatric experience is a plusAnalytical — comfortable working with IQVIA data, sales reports, and brand planning frameworksStrong communication and stakeholder collaboration skillsProactive, self-driven, and comfortable working in a fast-paced, matrixed environmentPfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers. Marketing and Market Research